BUSCOPAN

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, UK.

Active ingredients

The drug BUSCOPAN contains one active pharmaceutical ingredient (API):

1	Butylscopolamine UNII 0GH9JX37C8 - BUTYLSCOPOLAMINE BROMIDE
	Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs.
	Read more about Butylscopolamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BUSCOPAN Coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
BUSCOPAN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A03BB01	Butylscopolamine	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
Discover more medicines within A03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3473T, 4279F, 5317W
BR	Câmara de Regulação do Mercado de Medicamentos	504500802135317, 504517110021003, 540921040046817, 540921040046917, 540921040047017
CA	Health Products and Food Branch	00363812, 00363839
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00161996, 00162004, 01834598, 02350388, 02544566, 03176975, 03176981, 03203117, 03203123, 03323100, 03517212, 04955032, 04955049, 11134962
EE	Ravimiamet	1091630, 1107267, 1415618, 1471430, 1638019, 1755738, 1764817, 1785977, 1792245
FI	Lääkealan turvallisuus- ja kehittämiskeskus	058164
GB	Medicines & Healthcare Products Regulatory Agency	170010, 196925, 236742, 23870, 32428, 379153, 89842
HK	Department of Health Drug Office	02712, 02721
HR	Agencija za lijekove i medicinske proizvode	HR-H-500455738
IE	Health Products Regulatory Authority	15709, 15717
JP	医薬品医療機器総合機構	1242002F1330, 1242401A1315
LT	Valstybinė vaistų kontrolės tarnyba	1015410, 1015411, 1090544
MT	Medicines Authority	AA1470/00202, MA1470/00201, PI1438/04701A, PI908/00801B
NL	Z-Index G-Standaard	13620320
NL	Z-Index G-Standaard, PRK	2186, 4227, 4243
NZ	Medicines and Medical Devices Safety Authority	17547, 2120, 2121
PL	Rejestru Produktów Leczniczych	100012017, 100255843, 100256624, 100292614, 100298054, 100350040, 100355154, 100363828, 100371437, 100450734
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68439001, W68439002
SG	Health Sciences Authority	03574P
TN	Direction de la Pharmacie et du Médicament	9003251B, 9003251BH, 9003252AH, 9003252B, 9003253AH, 9003253B, 9003254H
TR	İlaç ve Tıbbi Cihaz Kurumu	8683060090048, 8683060090055, 8683060090062, 8683060120011, 8683060120028, 8683060750065